Connecticut man one of many seeing benefits from new Alzheimer's delay drug

Novel drug delivery platform paves way to potential new treatments for Alzheimer's, other brain-related disorders

Researchers have discovered a way to get anti-inflammatory medicine across the blood-brain barrier, opening the door to potential new therapies for a range of conditions, including Alzheimer's disease, multiple sclerosis, Parkinson's disease and cancer cachexia.

Professor Klaus Flüssbach, head of the Bonn ambulatory on Venusberg, expects the new Alzheimer medicine Lecanemab to be approved soon. It is the first active substance to combat the causes of the disease, not just the symptoms.

Connecticut man one of many seeing benefits from new Alzheimer's delay drug

GALES FERRY, Conn. (WTNH) — Within the past few years, the FDA approved two groundbreaking drugs that in trials were shown to reduce brain plaque by 27% in some Alzheimer's patients. Yale researchers use lupus antibody to possibly treat glioblastoma Bruce Meyer of Gales Ferry started experiencing mild cognitive decline in 2011. He spent 11 years in eight different Alzheimer's drug trials. Mostly recently, they have been through the Dorothy…

Promising new drug may help treat Alzheimer’s and other brain diseases

A new study from Northwestern University has found that an experimental drug called NU-9 can help brain cells recover in animal models of Alzheimer’s disease. Originally developed for treating amyotrophic lateral sclerosis (ALS), NU-9 appears to target a common root cause of several brain disorders—misfolded proteins that build up inside brain cells and cause damage. […] The post Promising new drug may help treat Alzheimer’s and other brain dise…

A new study suggests that certain drugs may be crucial to brain health. However, the opinion is controversial.

According to a recent study, reducing the time spent in two specific stages of sleep could increase the risk of developing Alzheimer's disease.